Advanced Diagnostic Testing

My Florida Medical Director is physician-owned and physician-led, providing ongoing clinical governance with direct physician involvement and accountability. We review the agreed testing menu, provider roles, documentation, results follow-up, and referrals within Medical Wellness governance. Your treating clinicians evaluate patients, order appropriate tests, interpret results within their competence, and manage care.

Advanced-testing protocol development is $500 one time for the agreed scope. The clinical foundation is included in the agreed package, with no separate foundation charge. We define the selected testing menu, patient preparation, consent, ordering, results review, referrals, and follow-up. Initial vendor and ancillary-service setup is part of the common foundation. Existing templates are reviewed and individualized. Testing-provider charges and onsite diagnostic equipment are separate.

Selected whole-body MRI referrals, blood-based multi-cancer detection (liquid biopsy), coronary calcium scoring or CCTA with plaque analysis when appropriate, and DXA for bone density or body composition. Whole-body MRI and multi-cancer blood tests do not replace established cancer screening. A positive signal requires diagnostic evaluation; a negative result does not rule out cancer. Routine whole-body MRI screening in average-risk people has not demonstrated improved longevity.

VO2 testing, lactate-threshold assessment, resting metabolic rate testing, and selected CGM assessment. Protocols define patient suitability, preparation, staff qualifications, equipment requirements, interpretation, and follow-up.

ApoB, lipoprotein(a), and selected inflammatory or lipid markers interpreted alongside standard lipids, medical history, and overall cardiovascular risk. This extends clinically appropriate assessment rather than replacing routine care.

Targeted micronutrient evaluation, hereditary-risk testing, and selected pharmacogenetic testing, with counseling or specialist referral when indicated. Intracellular nutrient panels and epigenetic age profiles receive separate review because clinical usefulness and evidence vary. Routine weight-management or hormone monitoring remains part of its existing program.

HRV trends, referrals for formal autonomic evaluation, and clinically selected gastrointestinal or microbiome tests. HRV alone is not a complete autonomic evaluation, and microbiome sequencing alone does not diagnose intestinal permeability or establish treatment.

MFMD defines clinical criteria, reviews proposed laboratories and imaging or testing providers, and establishes results and escalation pathways. MFMD helps establish approved vendor accounts and ancillary workflows as part of the common foundation when needed. Your clinic signs its provider agreements and manages ongoing appointments, specimen logistics, and results tracking. Ancillary providers perform the tests and supply their agreed reports and specialist interpretation. Your clinical team communicates results and completes follow-up. Partner arrangements are established for your facility; no pre-existing network is promised.

Wellness & Aesthetic (aesthetics and IV therapy) is $1,500/month. Medical Wellness (GLP-1 weight management, BHRT/TRT, accepted peptides, ED, and advanced testing) is $1,500/month. Both groups together are $2,500/month. One APP per facility is included across the contracted groups; each additional APP is $500/month. Core aesthetic procedures are included in the group fee. Each selected Advanced category adds $500/month per facility, counted once across devices, brands, and treatment areas. Each supervised electrologist adds $1,000/month. DPC-only primary care is $2,000/month with one NP/PA and the applicable primary-care protocol included. ED and advanced testing require scope review. One-time development is based on the foundation and protocols your facility needs, as detailed below.

The clinical foundation is included in the selected protocol package, with no separate foundation charge. It covers the agreed operational manual, clinical responsibilities and delegation, evaluation and ordering workflow, consent and digital records, infection control, medication handling, emergency response and quality follow-up. Existing suitable documents are reviewed and reused. Each selected service adds its own protocol details.

Protocol development: GLP-1 weight management $500; BHRT/TRT $500; IV therapy with an NP/PA $1,000. The accepted advanced peptide package is $1,000. Weight-management and advanced peptide protocols developed together are $1,500 in total. Advanced-testing protocol development is $500; ED is quoted after scope review. Core aesthetic protocols are $500 per selected family. Advanced procedure/device protocols are $500 each; laser/energy within a broader practice includes one device, with $250 per additional machine protocol. The clinical foundation is included in the selected package. Existing usable protocols are reviewed and individualized; full development is charged only when requested and needed. DPC includes the applicable primary-care collaboration protocol, with no separate standard setup charge.

Medical Wellness programs use a qualified treating NP/PA. DPC may use a qualified primary-care physician or NP/PA; registered autonomous primary-care practice is considered within its authorized scope. For aesthetics, MFMD accepts APP participation within mixed practices whose clinical activity is primarily medical; laser hair removal alone has its own acceptance pathway. Laser hair removal combined only with Botox does not require adding Medical Wellness. The assigned physician confirms procedure-specific scope according to personnel, device, and treatment area during the facility assessment.

Initial vendor and ancillary-service setup is part of the common foundation when needed. Ongoing MFMD physician participation to open and maintain pharmacy or medical-supply accounts is an optional $500/month per facility, subject to prior MFMD approval of the sources and requested support. Facilities maintaining their own accounts do not incur this monthly fee. Medicines, supplies, testing, equipment, and third-party services are separate.

Choose your services and describe your team and existing clinical documents. MFMD confirms the agreed scope, physician involvement, and activation date after review. A HIPAA-compliant digital clinical platform with documented patient encounters and physician access must be in use before services begin. Appointment software alone and paper-only records do not meet this requirement.

The initial payment is due on the effective date of the Agreement, unless a different due date is expressly stated in the payment schedule. Recurring due dates follow the agreed schedule. Governance begins on the agreed commencement date after the required clinical readiness steps are complete. Signing, payment and clinical activation are separate milestones.